E-LIB Suche - Ergebnisse für: Havrdova, Eva

1

Long-Term Treatment With First-Line Ocrelizumab in Patients..:

Cerqueira, Joao ; Berthele, Achim ; Cree, Bruce...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

2

Time course of lesion-induced atrophy in multiple sclerosis:

Carolus, Keith ; Fuchs, Tom A. ; Bergsland, Niels...
Journal of Neurology. 269 (2022) 8 - p. 4478-4487 , 2022

Link: https://doi.org/10.1007/..

3

Evaluating No Evidence of Disease Activity in Patients With..:

Kappos, Ludwig ; Comi, Giancarlo ; Selmaj, Krzysztof...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

4

Assessment of T2 lesion-based disease activity volume outco..:

Oship, Devon ; Jakimovski, Dejan ; Bergsland, Niels...
Multiple Sclerosis and Related Disorders. 67 (2022) - p. 104187 , 2022

Link: https://doi.org/10.1016/..

5

High and low efficacy therapy in secondary progressive mult..:

Roos, Izanne ; Leray, Emmanuelle ; Casey, Romain...
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..

6

Comparative Effectiveness and Cost-Effectiveness of Nataliz..:

Spelman, Timothy ; Herring, William L. ; Zhang, Yuanhui...
PharmacoEconomics. 40 (2021) 3 - p. 323-339 , 2021

Link: https://doi.org/10.1007/..

7

Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Preg..:

Yeh, Wei Zhen ; Widyastuti, Putu Ayu ; Van der Walt, Anneke...
Neurology. 96 (2021) 24 - p. , 2021

Link: https://doi.org/10.1212/..

8

Comparative effectiveness of natalizumab and fingolimod in ..:

Sharmin, Sifat ; Lefort, Mathilde ; Andersen, Johanna Balslev...
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..

9

Treatment Satisfaction in Patients with Highly-active Relap..:

Brochet, Bruno ; Hupperts, Raymond ; Langdon, Dawn...
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..

10

Effects of High- and Low-Efficacy Therapy in Secondary Prog..:

Roos, Izanne ; Leray, Emmanuelle ; Casey, Romain...
Neurology. 97 (2021) 9 - p. , 2021

Link: https://doi.org/10.1212/..

11

Delay from treatment start to full effect of immunotherapie..:

Roos, Izanne ; Leray, Emmanuelle ; Frascoli, Federico...
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..

12

Variability of the Response to Immunotherapy Among Sub-grou..:

Diouf, Ibrahima ; Malpas, Charles ; Horakova, Dana...
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..

13

Lower Long-Term Disability with Early Start of High-Efficac..:

He, Anna ; Merkel, Bernd ; Brown, J William...
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

14

Immunotherapies Improve Long-Term Disability Outcomes in Re..:

Kalincik, Tomas ; Diouf, Ibrahima ; Malpas, Charles...
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

15

Predicting Long-Term Sustained Disability Progression in Mu..:

Sharmin, Sifat ; Bovis, Francesca ; Malpas, Charles...
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..